ArticleInternational journal of nephrology and renovascular disease2017

Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trial.

Larry A Weinrauch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.